| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternative transcription and alternative splicing in cancer
|
Pal, Sharmistha
|
|
2012
|
136 |
3 |
p. 283-294
12 p.
|
artikel
|
| 2 |
Basic mechanisms of migraine and its acute treatment
|
Edvinsson, Lars
|
|
2012
|
136 |
3 |
p. 319-333
15 p.
|
artikel
|
| 3 |
Biologically-based modeling insights in inhaled vapor absorption and dosimetry
|
Morris, John B.
|
|
2012
|
136 |
3 |
p. 401-413
13 p.
|
artikel
|
| 4 |
Blinatumomab: A historical perspective
|
Nagorsen, Dirk
|
|
2012
|
136 |
3 |
p. 334-342
9 p.
|
artikel
|
| 5 |
Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential
|
Liu, Tuoen
|
|
2012
|
136 |
3 |
p. 354-374
21 p.
|
artikel
|
| 6 |
Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury
|
Matheeussen, Veerle
|
|
2012
|
136 |
3 |
p. 267-282
16 p.
|
artikel
|
| 7 |
Emerging real-time technologies in molecular medicine and the evolution of integrated ‘pharmacomics’ approaches to personalized medicine and drug discovery
|
Milward, Elizabeth A.
|
|
2012
|
136 |
3 |
p. 295-304
10 p.
|
artikel
|
| 8 |
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: Evidence from the bench and the bedside
|
Graves, Steven M.
|
|
2012
|
136 |
3 |
p. 343-353
11 p.
|
artikel
|
| 9 |
SIRT1 in metabolic syndrome: Where to target matters
|
Wang, Yu
|
|
2012
|
136 |
3 |
p. 305-318
14 p.
|
artikel
|
| 10 |
The genetics of selective serotonin reuptake inhibitors
|
Kroeze, Yvet
|
|
2012
|
136 |
3 |
p. 375-400
26 p.
|
artikel
|
Tijdschrift beschrijving